Table 2.
Human |
Human |
Rat |
Mouse |
Porcine |
||||
---|---|---|---|---|---|---|---|---|
Disaccharide | HCC ± SD (n=7) | Non-fibrotic peritumoral liver ± SD (n=7) | Healthy liver ± SD (n=1) | Healthy livera | HepG2 HCC cell lineb | Healthy liverc | Healthy liver (male)d | Healthy livere |
ΔHexA-GlcNAc | 50.4 ± 2.2 | 48.9 ± 0.9 | 49.2 | 37.3 | 46.1 | 31.4 | 50.9 | 47.9 |
ΔHexA-GlcNS | 22.5 ± 1.2 | 20.6 ± 1.2 | 19.8 | 15.5 | 22.9 | 18.0 | 10.2 | 10.8 |
ΔHexA-GlcNAc(6S) | 7.8 ± 1.5 | 11.6 ± 1.2 | 11.4 | 9.8 | 9.9 | 6.2 | 12.4 | 10.2 |
ΔHexA(2S)-GlcNAc | 1.1 ± 0.4 | 1.2 ± 0.4 | 2.3 | 1.2 | 2.9 | 1.2 | ND | 0 |
ΔHexA-GlcNS(6S) | 3.6 ± 0.8 | 4.8 ± 0.6 | 4.6 | 7.8 | 6.5 | 7.1 | 5.1 | 5.6 |
ΔHexA(2S)-GlcNS | 7.8 ± 1.2 | 6.4 ± 0.9 | 6.1 | 5.9 | 4.4 | 14.4 | 4.4 | 4.4 |
ΔHexA(2S)-GlcNAc(6S) | ND | ND | ND | 0.7 | 0.6 | 0.5 | <0.5 | 0.0 |
ΔHexA(2S)-GlcNS(6S) | 6.5 ± 1.2 | 6.2 ± 0.6 | 6.6 | 21.8 | 6.7 | 21.2 | 17.0 | 21.2 |
Sulfate | ||||||||
N-sulfates | 40.5 ± 2.2 | 38.2 ± 2 | 37.1 | 51.0 | 40.5 | 60.7 | 36.7 | 42.0 |
2-O-sulfates | 15.4 ± 1.8 | 13.9 ± 1.1 | 15.1 | 29.6 | 14.6 | 37.3 | 21.4 | 25.6 |
6-O-sulfates | 18.0 ± 2.9** | 22.7 ± 1.1** | 22.6 | 40.1 | 23.7 | 35.0 | 34.5 | 37.0 |
Total O-sulfates | 33.5 ± 3.7* | 36.7 ± 0.7* | 37.7 | 69.7 | 38.3 | 72.3 | 55.9 | 62.6 |
Total sulfates | 74.0 ± 5.2 | 75.0 ± 2.1 | 74.8 | 120.7 | 78.8 | 133.0 | 92.6 | 104.6 |
Data from Vongchan et al. (2005).
Data from Barth et al. (2003).
Data from Deakin and Lyon (2008).
Data from Warda et al. (2006).
Data from Toida et al. (1997).
Difference significant at p=0.048.
Difference significant at p=0.002.
Disaccharide analyses of HS from peritumoral non-fibrotic liver tissue and hepatocellular carcinoma (HCC) compared with that from healthy liver of human, rat, mouse, and porcine origin. ΔHexA corresponds to the 4,5-unsaturated uronate residue, of either glucuronate or iduronate origin, that is generated by the lyase action of the heparinases. SD, standard deviation; ND, not determined.